Skip to content

Effect of Metformin on Exercise-induced Lipolysis

New Electrophoretic Approaches in Studies of Obesity and Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03189732
Enrollment
10
Registered
2017-06-16
Start date
2015-10-01
Completion date
2018-01-31
Last updated
2020-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

lipolysis, adipose tissue, exercise

Brief summary

The aim of this study is to investigate whether metformin has inhibitory effect on exercise-induced lipolysis in subcutaneous adipose tissue in healthy lean man. Ten healthy lean mean will follow protocols consisting of 60 minutes of exercise on bicycle ergometer combined with a) orally administered metformin and b) locally administered metformin into adipose tissue and c) without metformin treatment. Microdialysis is used for assessment of metabolites in situ in subcutaneous adipose tissue.

Detailed description

Metformin and physical activity are often recommended as the first therapeutic agents to improve glycemic control for prediabetes and type 2 diabetes (ADA). It has been reported that metformin decrease plasma concentration of non-esterified fatty acids in patients with type 2 diabetes which might be associated with the inhibition of lipolysis in adipose tissue. However, the inhibition of lipolysis during physical exercise, would not be probably beneficial. Thus, the effect of metformin on lipolysis during exercise is investigated in this protocol. As the lipolysis regulation is often impaired in obese and diabetic patients, the healthy lean men were chosen for this pilot study. Glycerol will be analyzed as a measure of lipolytic rate in adipose tissue and in plasma. Lactate levels will be observed. Our findings should provide a new background about the combination of physical activity and metformin medication.

Interventions

DRUGMetformin Oral
DRUGMetformin local in AT
OTHERExercise

Sponsors

Charles University, Czech Republic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
25 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy lean men, non obese, BMI 20-28 kg/m2

Exclusion criteria

* weight change within the 3 months before the study, * hypertension, * impaired fasting glucose * diabetes * hyperlipidemia * drug or alcohol abuse * smoking

Design outcomes

Primary

MeasureTime frameDescription
Change in adipose tissue lipolysis in response to exerciseMinute -60, 15, 30, 45, 60 and 120 from the start of exerciseGlycerol concentration in dialysate outcoming from adipose tissue and in plasma - kinetic study

Secondary

MeasureTime frameDescription
Change in lactate production in response to exerciseMinute -60, 15, 30, 45, 60 and 120 from the start of exerciseConcentration of lactate in dialysate and in plasma - kinetic study

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026